The Greater Manchester Collaborative Procurement Hub (CPH) has placed an order with Philips’ distributors in the UK, Cardiac Services, for the purchase of a million pounds worth of monitor/defibrillators, including the HeartStart MRx and HeartStart FR2+.
CPH is entirely owned and funded by Manchester’s 28 NHS organisations and was formed to gain a better deal for everyone, by ensuring an aggregation of spend and taking advantage of economies of scale.
The HeartStart MRx is said to be a reliable and easy-to-use monitor/defibrillator designed with a broad range of features and capability to meet the technical demands of Advanced Cardiac Life Support-trained caregivers in emergency medical services and hospital environments. It combines monitoring technology with diagnostic measurements and Philips’ patented resuscitation therapies in a single lightweight device.
The HeartStart FR2+ is portable, lightweight and requires minimal training. It automatically determines whether a shock is required with the same accuracy as a trained observer of heart rhythms. It is optimised for fast efficiency operation and rapid delivery of life-saving therapy.
Commands are clear, streamlined, confident and concise.
Mark Peacock, UK sales manager, Cardiac Services, UK, says: “One of the factors influencing the sale was the new technology, for instance the Quick shock and Smart CPR on the FR2 AED. Until recently, the use of defibrillators required considerable training and skill, but HeartStart FR2+ has meant that trained Basic Life Support teams can carry out the defibrillation. Training a new tier of staff can help to broaden the support net, as nurses and other personnel, often the first to respond to a patient in distress, will find HeartStart FR2+ simple and easy to use.”
